Table:
begin	end	state
1	50	non-cytoplasmic
51	74	transmembrane
75	110	cytoplasmic
111	132	transmembrane
133	151	non-cytoplasmic
152	175	transmembrane
176	183	cytoplasmic
184	206	transmembrane
207	226	non-cytoplasmic
227	249	transmembrane
250	268	cytoplasmic
269	290	transmembrane
291	310	non-cytoplasmic
311	338	transmembrane
339	360	cytoplasmic
361	381	transmembrane
382	386	non-cytoplasmic
387	410	transmembrane
411	417	cytoplasmic
418	437	transmembrane
438	451	non-cytoplasmic
452	471	transmembrane
472	481	cytoplasmic

Input:
>GFF2255
MIAIGVFAMRRATSSSEDYMLGGRALSPKVAALSAGASDMSGWLLLGLPRALFASGLGSA
WIGIGLLVGAFFNWTLVAPRLREQTVHYGNAITIPSFLANRFPTQALSLRTVSAIVIVIF
FAVYTASGLVAGGKLFESAFSGIFNFGGLSDYAVGIVITLGVVLAYTVVGGFLAVSLTDF
VQGCIMMLALVIMPAVVLFGEGGGGFAQASQTLNEVDPTLLSWTEGLTFIGWLSAVTWGL
GYFGQPHIIVRFMAIRTLKDVPVARNIGMSWMLISLIGAISLGVFGRAYAIRNGMDVQDP
ETIFIILSDMLFHPLITGFLYAALLAAVMSTISSQLLVSSSSLTEDFYRLFLRKEASDKE
CVNIGRVCVVLVGLVAAVIASDPNSQVLALVANAWAGFGAAFGPLIILSLMWPRTNGAGA
IAGMVVGAATVMIWISLGWNGSFMGGPGVYEIIPGFIAAFIAILVVSSATADAGEYQHIE
R

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server